(200 days)
The SonoTT FlowLab® with the accessories is a system to measure the flow rate of liquids (e.g. blood) with the ultrasonic transit-time and velocity patterns of blood with Doppler method. It supports the planning, implementation, efficiency control and documentation of interventions carried out in the area of cardiovascular, vascular and, transplantation, or the monitoring of extracorporeal circulatory systems.
The following medical applications are supported:
- Intraoperative blood flow measurement with the SonoTT Vascular Probe to assist e surgeons at surgical interventions
- Measurement of flow direction and velocities of blood in vessels using the SonoTT Pulse . Wave Doppler Probe to assist the surgeon in the non-invasive assessment of vascular changes.
- Extracorporeal flow measurement in continuous operation on tube systems in . combination with the SonoTT Clamp-On Transducer in intensive care units and operating theatres
The following actions can be performed simultaneously when these measurements are in progress:
- Pressure measurement in combination with a standard blood pressure transducer t
- Secondary displays of additional physiological analogue signals and corresponding . derived parameters
The SonoTT Vascular Probe is intended for transient use only with continuous contact with patient of less than 60 minutes.
The SonoTT FlowLab® is used for the volumetric measurement of liquid flowing through tubing systems (in combination with the SonoTT Clamp-On Transducer), to measure blood volume flow (in combination with the SonoTT Vascular Probe) and flow velocity in arteries and veins (in combination with the SonoTT Pulse Wave Doppler Probe). The measurement principle is the ultrasound transit-time and Doppler method.
The SonoTT FlowLab® is a blood flow meter that uses ultrasound transit-time and Doppler methods to measure liquid flow rate and blood velocity. It is intended for use in cardiovascular, vascular, and transplantation interventions, as well as for monitoring extracorporeal circulatory systems.
Acceptance Criteria and Device Performance:
The provided document does not explicitly state quantitative acceptance criteria for device performance (e.g., specific accuracy thresholds for flow measurement). Instead, the substantial equivalence argument relies on demonstrating that the SonoTT FlowLab® performs as well as the predicate devices (MediStim VeriQ and SonoTT Ultrasonic Flowcomputer) based on intended use, patient population, measurement and sensor technology, and auxiliary channels.
However, the "Test Data" section indicates that various tests were performed to "assure reliable design and performance under the specified testing parameters." While the results are not detailed in the provided text, the successful completion of these tests suggests that the device met internal performance benchmarks.
| Acceptance Criteria Category (Implied) | Reported Device Performance |
|---|---|
| Electrical Safety | Passed Electrical Safety Testing |
| Electromagnetic Compatibility (EMC) | Passed EMC Testing |
| Ultrasonic Acoustic Output | Passed Ultrasonic Acoustic Output Testing |
| Alarm Functionality | Passed Alarm Testing |
| Software Validation | Passed Software Validation |
| Mechanical Stability | Passed Mechanical Stability Testing |
| Packaging Integrity | Passed Packaging Testing |
| Biocompatibility (Vascular/Pulse Wave Doppler Probes) | Passed Biocompatibility Evaluation |
| Sterility (Vascular Probe) | Passed Sterility Evaluation |
| Usability | Passed Usability Validation |
Study Information:
-
Sample Size Used for the Test Set and Data Provenance:
- The provided document does not specify sample sizes for any of the performance tests (e.g., number of measurements, number of devices tested).
- There is no information regarding the data provenance (e.g., country of origin, retrospective or prospective nature).
-
Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:
- The document does not mention the use of experts to establish ground truth for the device performance tests. These tests (Electrical Safety, EMC, etc.) are typically evaluated against established engineering standards and specifications rather than expert consensus on clinical data.
-
Adjudication Method for the Test Set:
- Not applicable as the nature of the described tests does not involve a need for adjudication in the context of clinical expert review.
-
Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
- No, a multi-reader multi-case comparative effectiveness study comparing human readers with and without AI assistance was not mentioned or performed. The device is a measurement instrument, not an AI diagnostic tool that assists human readers in interpreting medical images or data.
-
Standalone (Algorithm Only Without Human-In-The-Loop Performance) Study:
- While the device functions as a standalone measurement instrument, the document does not describe a formal "standalone study" in the context of comparing its performance against a human operator or a gold standard algorithmically. The validation tests listed (electrical safety, EMC, etc.) focus on the device's adherence to regulatory and engineering standards.
-
Type of Ground Truth Used:
- For the technical and performance tests listed (Electrical Safety, EMC, etc.), the "ground truth" would be established engineering standards, regulatory requirements, and internal design specifications.
- For the core function of flow measurement, the accuracy would typically be validated against a known physical standard (e.g., a calibrated flow measurement system), though the details of such validation are not provided.
-
Sample Size for the Training Set:
- Not applicable. The SonoTT FlowLab® is a hardware-based measurement device, not an AI or machine learning algorithm requiring a "training set" in the conventional sense. Its functionality is based on established physical principles (ultrasound transit-time and Doppler).
-
How the Ground Truth for the Training Set Was Established:
- Not applicable, as there is no training set for this type of device.
{0}------------------------------------------------
KII1730
JAN - 6 2012
510(K) SUMMARY
Submitter Information
Contact Person :
Phone: Fax: E-Mail:
em-tec GmbH Lerchenberg 20 86923 Finning Germany www.em-tec.de
Mr. B. Brand Regulatory Affairs Manager +49(0)8806 9236 21. +49(0)8806 9236 50, bernhard.brand@em-tec.de
Date Prepared
Device Name
Trade/Proprietary Name:
Common/Usual Name:
Classification Name:
June 6, 2011
SonoTT FlowLab®
Blood Flow Meter
Flowmeter, Blood, Cardiovascular
CFR § 870.2100 Product Code
DPW
Classification:
Class II
Predicate Device Name
MediStim VeriQ VQ1001- VQ4122 Trade name:
SonoTT Ultrasonic Flowcomputer
These devices are the same in terms of Intended use/Indication, clinical applications, type of construction, measurement technology, sensor types, energy source and emitted energy, anatomical sites and material/biocompatibility issues.
Device Description
The SonoTT FlowLab® is used for the volumetric measurement of liquid flowing through tubing systems (in combination with the SonoTT Clamp-On Transducer), to measure blood volume flow (in combination with the SonoTT Vascular Probe) and flow velocity in arteries and veins (in combination with the SonoTT Pulse Wave
{1}------------------------------------------------
Doppler Probe). The measurement principle is the ultrasound transit-time and Doppler method. ،
Substantial Equivalence
.
.
がない。
『
| Medi-Stim VeriQ | SonoTT UltrasonicFlowcomputer | SonoTT FlowLab® | |
|---|---|---|---|
| VQ1001- VQ4122 | |||
| Indicationsfor use | The Medi-Stim VeriQSystem is anintraoperativediagnostic system thatutilizesultrasonography toguide surgeons tosuccessfully plan andaccomplish surgicalinterventions. | The Sono TT UltrasonicFlowcomputer isindicated for thevolumetric measurementof liquid flowing throughtubing systems ( withClamp-On Transducer).The measurementprinciple is theultrasound transit-timemethod. TheFlowcomputer isdesigned for continuousoperation in intensivecare unitsand operating rooms. Forthe patient's safety thedevice is to be operatedonly by qualifiedmedically-trainedpersonnel. | The SonoTT FlowLab®with the accessories is asystem to measure theflow rate of liquids (e.g.blood) with the ultrasonictransit-time and velocitypatterns of blood withDoppler method. Itsupports the planning,implementation, efficiencycontrol and documentationof interventions carried outin the area ofcardiovascular, vascularand, transplantation, or themonitoring ofextracorporeal circulatorysystems. |
| The clinical indicationsfor the device are: | The medical use of thedevice is appropriate toprocedures such as thefollowing: | The following medicalapplications aresupported: | |
| 1) Accurate transittime blood volume andDoppler velocity flowmeasurements duringcardiovascular-,vascular-,transplantation- andneuro-surgery | 1) Extracorporeal flowmeasurement on tubingswith Clamp-OnTransducer duringinterventions like Cardio-pulmonary bypass,membrane-oxygenation,hemodialysis;hemofiltration,plasmapheresis,perfusion, infusion,transfusion | 1) Intraoperative bloodflow measurement with theSonoTT Vascular Probe toassist surgeons at surgicalinterventions2) Measurement of flowdirection and velocities ofblood in vessels using theSonoTT Pulse WaveDoppler Probe to assist | |
| 2) Simultaneousmeasurements ofblood pressure,vascular resistance,interfacedphysiological signalsand other derivedparameters duringthese procedures.3) Detection of normal | the surgeon in the non-invasive assessment ofvascular changes.3) Extracorporeal flowmeasurement incontinuous operation ontube systems incombination with theSonoTT Clamp-OnTransducer in intensive | ||
| and abnormal blood | |||
| volume and Doppler | care units and operating | ||
| velocity flow patterns | theatres | ||
| during these | The following actions can | ||
| procedures. | be performed | ||
| simultaneously when | |||
| these measurements are | |||
| 4) Provides guidance | in progress: | ||
| to prepare surgical | |||
| plans at the initiation of | 4) Pressure measurement | ||
| surgery and to support | in combination with a | ||
| the successful | standard blood pressure | ||
| accomplishment of | transducer | ||
| surgery including | |||
| detection and location | |||
| of vessels during | 5) Secondary displays of | ||
| additional physiological | |||
| surgical procedures. | analogue signals and | ||
| corresponding derived | |||
| parameters | |||
| 5) Detection and | The SonoTT Vascular | ||
| quantification of the | Probe is intended for | ||
| degree of stenosis in | transient use only with | ||
| arteries by using the | continuous contact with | ||
| Doppler velocity | |||
| profile. | patient of less than 60 | ||
| minutes. | |||
| For the patient's safety | |||
| they must be operated by | |||
| qualified medical | |||
| personnel. | |||
| Patient | Adult and pediatric | No restrictions acc. | Aduit and pediatric |
| group | operator manual | ||
| Not intended for any | Not intended for | ||
| kind of fetal | examination of foetuses | ||
| applications. acc. | (prenatal) and neonates | ||
| operator manual | (foetal) . | ||
| Ultrasound | Transit-time, | Transit time, | Transit time, |
| modalities | |||
| PW Doppler | PW Doppler | PW Doppler | |
| Measureme | Vessel transducer, | ||
| nt Probes | Doppier Probe | Clamp-on Sensor | Vessel transducer, |
| Doppler Probe, | |||
| Clamp-on Sensor | |||
| Otherinputs | Blood pressure, ECG,Auxiliary inputs | Blood pressure, Auxiliaryinputs | Blood pressure, ECG,Auxiliary inputs |
{2}------------------------------------------------
The proposed device is substantial equivalent to the predicate devices with respect to intended use, patient population, measurement and sensor technology and auxiliary channels. Therefore it meets the requirements for section 510(k) substantial equivalence and is as safe, as effective, and performs as well as the predicate devices
{3}------------------------------------------------
Test Data
The SonoTT FlowLab® and the accessories were subjected to the following tests to assure reliable design and performance under the specified testing parameters. These tests were comprised of:
-
- Electrical Safety Testing
- EMC Testina 2.
- Ultrasonic acoustic output testing က
-
- Alarm testing
- క్. Software Validation
-
- Mechanical Stability Testing
-
- Packaging Testing
-
- Biocompatibility evaluation of Vascular Probe and Pulse Wave Doppler Probe
- တ် Sterility evaluation of Vascular Probe
-
- Usability Validation
The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its use as a Blood Flow Meter.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is a stylized symbol that resembles an abstract caduceus, a symbol often associated with medicine and healthcare.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JAN - 6 2012
em-tec GmbH c/o Mr. Olaf Teichert TÜV SÜD America, Inc. 1775 Old Highway 8 NW, Ste 104 New Brighton, MN 55112-1891
K11730 Re:
Trade/Device Name: SonoTT FlowLab® Flowmeter Regulation Number: 21 CFR 870.2100 Regulation Name: Cardiovascular Blood Flowmeter Regulatory Class: Class II (two) Product Codes: DPW, ITX Dated: December 28, 2011 Received: December 30, 2011
Dear Mr. Teichert:
We have reviewed your Section 510(k) premarket notification of intent to market the device indication We have reviewed your Section 910(x) premainted is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encrosule for tegary manated to of the Medical Device Ameral Food Drug commerce prior to May 28, 1776, the enacintent with the provisions of the Federal Food. Drug, devices that have been reciassified in accordance with and proval application (PMA).
and Cosmetic Act (Act) that do not require approval of a premarket approval or of the Act and Cosment Act (Act) that do not require approval controls provisions of the Act. The Act. The Act. The Act. The You may, therefore, market the device, becjost to the group registration, listing of
general controls provisions of the Act include requirements for annual registration, and general controls provisions of the trectine, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), If your device is classified (SC above) into extine major regulations affecting your device can be
it may be subject to additional controls. Existing major regulation affect if may be subject to additional controls. Entroling major and on 898. In addition, FDA may lound in the Code of I cacial Regulations, Four device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that I DA s issuated on a banded with other requirements of the Act
that FDA has made a determination that your device complies - You must that FDA has made a decemmanon alla Jour access of by other Federal agencies. You must
{5}------------------------------------------------
Page 2 – em-tec GmbH c/o Mr. Olaf Teichert
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
for Bram D. Zuckerman, M.D.
Director
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure
{6}------------------------------------------------
| 510(k) Submission Section D | SonoTT FlowLab | ||
|---|---|---|---|
| Indications for Use | FL-FDIU-1.1.doc | 05/26/11 | -em-tec MEDICAL TECHNOLOGY |
Indications for Use
510(k) Number (if known): _ K | | 7 30
Device Name: SonoTT FlowLab
Indications for Use
The SonoTT FlowLab® with the accessories is a system to measure the flow rate of liquids (e.g. blood) with the ultrasonic transit-time and velocity patterns of blood with Doppler method. It supports the planning, implementation, efficiency control and documentation of interventions carried out in the area of cardiovascular, vascular and, transplantation, or the monitoring of extracorporeal circulatory systems.
The following medical applications are supported:
- Intraoperative blood flow measurement with the SonoTT Vascular Probe to assist e surgeons at surgical interventions
- Measurement of flow direction and velocities of blood in vessels using the SonoTT Pulse . Wave Doppler Probe to assist the surgeon in the non-invasive assessment of vascular changes.
- Extracorporeal flow measurement in continuous operation on tube systems in . combination with the SonoTT Clamp-On Transducer in intensive care units and operating theatres
The following actions can be performed simultaneously when these measurements are in progress:
- Pressure measurement in combination with a standard blood pressure transducer t
- Secondary displays of additional physiological analogue signals and corresponding . derived parameters
The SonoTT Vascular Probe is intended for transient use only with continuous contact with patient of less than 60 minutes.
.............................................................................................................................................
For the patient's safety they must be operated by qualified medical personnel.
Contraindication
The SonoTT FlowLab® and the accessories Vascular Probe, Clamp-On Transducer and Pulse Wave Doppler Probe were exclusively designed for the described intended use.
The device is expressly not intended for the following:
- The Vascular Probe for measurements on stented areas of blood vessels. .
- Examination of foetuses (prenatal) and neonates (foetal) with the Doppler Probe .
- Doppler measurements of eyes (ophthalmology), in gynaecology or in obstetrics .
- Monitoring of vital physiological parameters .
- Measurements at human arteries or veins using the Clamp-On Transducer .
Applicant: em-tec GmbH, Lerchenberg 20, 86923 Finning, Germany, www.em-tec.de Phone: +49(0)8806 9236 0, Fax: +49(0)8806 9236 50, info@em-tec.de Contact Person: Mr. B. Brand, Phone: +49(0)8806 9236 21, bernhardbrand(@)em-tec.de 1/2
{7}------------------------------------------------
| 510(k) Submission Section D | SonoTT FlowLab | ||
|---|---|---|---|
| Indications for Use | FL-FDIU-1.1.doc | 05/26/11 | -- em-tecMEDICAL TECHNOLOGY |
Prescription Use Yes (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use No (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Cardiovascular Devices
510(k) Number_ 11/730
Applicant: em-tec GmbH, Lerchenberg 20, 86923 Finning, Germany, www.em-tec.de Phone: +49(0)8806 9236 0, Fax: +49(0)8806 9236 50, info@em-tec.de Contact Person: Mr. B. Brand, Phone: +49(0)8806 9236 21, bernhardbrand(@em-tec.de
2/2
§ 870.2100 Cardiovascular blood flowmeter.
(a)
Identification. A cardiovascular blood flowmeter is a device that is connected to a flow transducer that energizes the transducer and processes and displays the blood flow signal.(b)
Classification. Class II (performance standards).